ALS took many things from columnist Juliet Taylor's late husband, Jeff, including the end of his career, which was ...

With the hold lifted, Amylyx can begin screening and enrolling for its Phase 1 LUMINA trial, which will test AMX0114 in ALS ...

Columnist Kristin Neva had been searching awhile for equipment that would help with her husband's ALS management. It took repeated searches.

The ALS Association will host its second ALS Nexus conference in August, with the goal of making the disease a livable one ...

Riluzole treatment and a diet containing high glycemic index foods interact 'synergistically' to slow ALS progression, ...

David Husman, a Chicago businessman, donated the money to advance an ALS and a neuroscience center where his wife had been ...

Half of ALS patients experience constipation, which is associated with faster progression and lower survival rates, per a ...

Eli Lilly partnership aims to identify new treatments for ALS based on antibodies from people with very slow disease ...

ALS patients' disease progression and improved functional independence and mobility in a real-world setting, per a study.

DNL343 and fosigotifator are made to activate the ISR pathway protein eIF2B, but both failed to slow ALS progression in the HEALEY trial.

The number of ALS cases in the U.S. is expected to increase by over 10% by 2030, as compared with 2022 prevalence rates, per new study data.

Team Gleason has expanded its collaboration with Stentrode developer Synchron to help teach people about brain-computer ...